21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
31.09.Z - Manufacture of furniture
32.50.Z - Production of medical devices, instruments, and products, including dental products
41.20.Z - Construction work related to the construction of residential and non-residential buildings
43.91.Z - Masonry works
46.46.Z - Wholesale trade of pharmaceutical and medical products
55.10.Z - Hotels and similar accommodation establishments
56.10.B - Food service activities
68.10.Z - Real estate activities on own account and development of building projects
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 8,2 | 11,2 | -22,1 | -296,7 |
EBITDA | 8,2 | |||
Income tax | 1 | 0 | -100 | |
Equity capital | -21,7 | -11,4 | -33,5 | -193,5 |
Operating profit (EBIT) | 8,2 | |||
Assets | 8 | 5 | 6,8 | 35 |
Net profit (loss) | 8,2 | 10,2 | -22,1 | -316,2 |
Net income from sale | 27,5 | |||
Liabilities and provisions for liabilities | 29,7 | 14,9 | 38,5 | 157,8 |
Working assets | 8 | 5 | 6,8 | 35 |
Depreciation | 0 | |||
Basic operational activity income | 83,6 | 50,9 | -39,2 | |
% | % | % | p.p. | |
Equity capital to total assets | -269,3 | -226,8 | -493 | -266,2 |
Gross profit margin | 29,6 | 13,4 | -43,5 | -56,9 |
EBITDA Margin | 29,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane